3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: December 18, 2014
Period of Report: December 17, 2014
Accession Number: 0001553878-14-000036

View Document ↗ View on SEC.gov ↗